Home - Products - Others - Other Targets - [Ala5, β-Ala8]-Neurokinin A (4-10)

[Ala5, β-Ala8]-Neurokinin A (4-10)

CAS No. 127633-71-0

[Ala5, β-Ala8]-Neurokinin A (4-10)( ——— )

Catalog No. M41435 CAS No. 127633-71-0

(β-Ala8)-Neurokinin A (4-10), a neuropeptide, is a potent and selective NK-2 tachykinin receptor (Neurokinin Receptor) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Ala5, β-Ala8]-Neurokinin A (4-10)
  • Note
    Research use only, not for human use.
  • Brief Description
    (β-Ala8)-Neurokinin A (4-10), a neuropeptide, is a potent and selective NK-2 tachykinin receptor (Neurokinin Receptor) agonist.
  • Description
    (β-Ala8)-Neurokinin A (4-10), a neuropeptide, is a potent and selective NK-2 tachykinin receptor (Neurokinin Receptor) agonist.
  • In Vitro
    ———
  • In Vivo
    (β-Ala8)-Neurokinin A (4-10) (2 μg/kg; i.v.) increases colonic tone in conscious female dogs.
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    127633-71-0
  • Formula Weight
    765
  • Molecular Formula
    C35H56N8O9S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. C A Maggi, et al. In vivo pharmacology of beta Ala8neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist.Eur J Pharmacol. 1990 Feb 20;177(1-2):81-6.?
molnova catalog
related products
  • Cibisatamab

    Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.

  • Jatamanvaltrate N

    The herbs of Valeriana jatamansi.

  • 3,4-Di-O-caffeoylqui...

    3,4-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV; it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells.